News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
171,351 Results
Type
Article (7668)
Company Profile (20)
Press Release (163662)
Multimedia
Podcasts (13)
Webinars (2)
Section
Business (55892)
Career Advice (354)
Deals (9837)
Drug Delivery (19)
Drug Development (22344)
Employer Resources (32)
FDA (3642)
Job Trends (3941)
News (88882)
Policy (6347)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (498)
Accelerated approval (7)
Adcomms (5)
Allergies (39)
Alliances (5806)
ALS (45)
Alzheimer's disease (398)
Antibody-drug conjugate (ADC) (94)
Approvals (3821)
Artificial intelligence (70)
Autoimmune disease (37)
Automation (7)
Bankruptcy (70)
Best Places to Work (3549)
BIOSECURE Act (4)
Biosimilars (47)
Biotechnology (15)
Bladder cancer (78)
Brain cancer (18)
Breast cancer (285)
Cancer (1811)
Cardiovascular disease (181)
Career advice (293)
Career pathing (3)
CAR-T (71)
CDC (7)
Cell therapy (201)
Cervical cancer (16)
Clinical research (20457)
Collaboration (269)
Company closure (1)
Compensation (167)
Complete response letters (10)
COVID-19 (569)
CRISPR (59)
C-suite (71)
Cystic fibrosis (30)
Data (2669)
Depression (41)
Diabetes (179)
Diagnostics (1628)
Digital health (7)
Diversity (3)
Diversity, equity & inclusion (12)
Drug discovery (47)
Drug pricing (25)
Drug shortages (4)
Duchenne muscular dystrophy (60)
Earnings (46943)
Editorial (11)
Employer branding (5)
Employer resources (26)
Events (34457)
Executive appointments (72)
FDA (4650)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (11)
Funding (221)
Gene editing (112)
Generative AI (6)
Gene therapy (196)
GLP-1 (338)
Government (919)
Grass and pollen (1)
Guidances (327)
Healthcare (4785)
HIV (21)
Huntington's disease (17)
IgA nephropathy (44)
Immunology and inflammation (75)
Immuno-oncology (14)
Indications (37)
Infectious disease (647)
Inflammatory bowel disease (50)
Inflation Reduction Act (2)
Influenza (38)
Intellectual property (36)
Interviews (69)
IPO (6169)
IRA (8)
Job creations (581)
Job search strategy (255)
JPM (7)
Kidney cancer (10)
Labor market (22)
Layoffs (160)
Leadership (3)
Legal (1183)
Liver cancer (28)
Longevity (2)
Lung cancer (262)
Lymphoma (200)
Machine learning (7)
Management (10)
Manufacturing (102)
MASH (70)
Medical device (3251)
Medtech (3265)
Mergers & acquisitions (3952)
Metabolic disorders (468)
Multiple sclerosis (59)
NASH (9)
Neurodegenerative disease (79)
Neuropsychiatric disorders (32)
Neuroscience (758)
NextGen: Class of 2026 (1320)
Non-profit (866)
Now hiring (14)
Obesity (219)
Opinion (42)
Ovarian cancer (43)
Pain (39)
Pancreatic cancer (70)
Parkinson's disease (82)
Partnered (5)
Patents (79)
Patient recruitment (96)
Peanut (16)
People (5124)
Pharmaceutical (4)
Pharmacy benefit managers (6)
Phase 1 (5337)
Phase 2 (8505)
Phase 3 (8333)
Pipeline (2454)
Policy (35)
Postmarket research (848)
Preclinical (1854)
Press Release (16)
Prostate cancer (78)
Psychedelics (12)
Radiopharmaceuticals (85)
Rare diseases (233)
Real estate (651)
Recruiting (8)
Regulatory (5331)
Reports (15)
Research institute (426)
Resumes & cover letters (52)
Rett syndrome (21)
RNA editing (2)
RSV (26)
Schizophrenia (55)
Series A (33)
Series B (22)
Sickle cell disease (48)
Special edition (7)
Spinal muscular atrophy (39)
Sponsored (8)
Startups (526)
State (1)
Stomach cancer (6)
Supply chain (20)
Tariffs (12)
The Weekly (13)
Vaccines (240)
Venture capital (19)
Weight loss (168)
Women's health (27)
Worklife (5)
Date
Today (7)
Last 7 days (144)
Last 30 days (457)
Last 365 days (9834)
2026 (651)
2025 (10061)
2024 (11373)
2023 (12820)
2022 (15347)
2021 (15099)
2020 (13778)
2019 (10992)
2018 (8211)
2017 (8221)
2016 (7145)
2015 (8991)
2014 (6199)
2013 (4618)
2012 (5210)
2011 (5393)
2010 (4871)
Location
Africa (148)
Alabama (23)
Alaska (1)
Arizona (58)
Arkansas (1)
Asia (10631)
Australia (1538)
California (3417)
Canada (996)
China (412)
Colorado (160)
Connecticut (133)
Delaware (161)
Europe (23832)
Florida (438)
Georgia (129)
Hawaii (1)
Idaho (8)
Illinois (229)
India (17)
Indiana (209)
Iowa (3)
Japan (173)
Kansas (35)
Kentucky (11)
Louisiana (13)
Maine (45)
Maryland (360)
Massachusetts (2545)
Michigan (68)
Minnesota (158)
Missouri (36)
Montana (8)
Nebraska (1)
Nevada (34)
New Hampshire (18)
New Jersey (1162)
New Mexico (1)
New York (924)
North Carolina (392)
North Dakota (2)
Northern California (1783)
Ohio (78)
Oklahoma (4)
Oregon (3)
Pennsylvania (751)
Puerto Rico (5)
Rhode Island (7)
South America (250)
South Carolina (4)
Southern California (1268)
Tennessee (29)
Texas (526)
United States (12206)
Utah (85)
Virginia (42)
Washington D.C. (15)
Washington State (267)
West Virginia (1)
Wisconsin (28)
171,351 Results for "9".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Merck Again Brings Out Big Bucks, Buys Cidara in $9.2B Antiviral Push
At $9.2 billion, the Cidara acquisition lands among the top 5 largest deals of the year.
November 14, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Daxor Corporation Announces $9 Million Registered Direct Offering
January 26, 2026
·
3 min read
Job Trends
9 Companies Hiring in New Jersey
Looking for a new opportunity in New Jersey? These nine companies have open roles that could be a great fit for you.
December 11, 2025
·
1 min read
·
Chantal Dresner
Press Releases
Alpha-9 Oncology Announces First Patient Dosed in Phase 1 Study of A9-3408 for the Treatment of Melanoma
December 4, 2025
·
3 min read
Press Releases
Piramal Pharma Limited Announces Results for Q3 and 9M FY26
January 29, 2026
·
7 min read
Press Releases
Zevra Therapeutics to Ring Nasdaq Stock Market Opening Bell on Monday, February 9, 2026
February 2, 2026
·
1 min read
Drug pricing
Trump Administration Reaches Pricing Agreements With 9 More Drugmakers
Leerink analysts hailed the deals as a sign that President Trump “is unlikely to attack the industry in 2026.”
December 22, 2025
·
2 min read
·
Nick Paul Taylor
Press Releases
VitriVax Awarded $9.9M Grant to Enable Scaling up of Clinical Manufacturing
October 15, 2025
·
2 min read
Press Releases
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum
December 29, 2025
·
1 min read
Immunology and inflammation
Lilly Establishes up to $1.9B Repertoire Deal in Second Immune Play of 2026
The Repertoire partnership is Lilly’s second immunology play of the year, after the acquistion of Ventyx in early January for a pipeline of NLRP3 assets.
January 29, 2026
·
2 min read
·
Tristan Manalac
1 of 17,136
Next
